MY101204A - Solubilization of protein aggregates - Google Patents
Solubilization of protein aggregatesInfo
- Publication number
- MY101204A MY101204A MYPI86000197A MYPI19860197A MY101204A MY 101204 A MY101204 A MY 101204A MY PI86000197 A MYPI86000197 A MY PI86000197A MY PI19860197 A MYPI19860197 A MY PI19860197A MY 101204 A MY101204 A MY 101204A
- Authority
- MY
- Malaysia
- Prior art keywords
- protein
- solubilization
- protein aggregates
- source
- cationic surfactant
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000007928 solubilization Effects 0.000 title 1
- 238000005063 solubilization Methods 0.000 title 1
- 239000003093 cationic surfactant Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPH381885 | 1985-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY101204A true MY101204A (en) | 1991-08-17 |
Family
ID=3771404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI86000197A MY101204A (en) | 1985-12-11 | 1986-12-11 | Solubilization of protein aggregates |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4797474A (enExample) |
| EP (1) | EP0226448B1 (enExample) |
| JP (1) | JPH0660198B2 (enExample) |
| CN (1) | CN86108729A (enExample) |
| AT (1) | ATE76878T1 (enExample) |
| AU (1) | AU597924B2 (enExample) |
| CA (1) | CA1281849C (enExample) |
| DE (1) | DE3685562T2 (enExample) |
| DK (1) | DK171331B1 (enExample) |
| ES (1) | ES2032194T3 (enExample) |
| GR (1) | GR3004903T3 (enExample) |
| MY (1) | MY101204A (enExample) |
| NO (1) | NO864990L (enExample) |
| NZ (1) | NZ218586A (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| AU612133B2 (en) * | 1987-02-20 | 1991-07-04 | Natinco Nv | Production of proteins in active forms |
| CA1305285C (en) * | 1987-04-21 | 1992-07-14 | Malcolm Roy Brandon | Production of proteins in active forms |
| US4931543A (en) * | 1987-05-11 | 1990-06-05 | Cetus Corporation | Process for recovering microbially produced interleukin-2 |
| US5654176A (en) * | 1987-05-28 | 1997-08-05 | Amrad Corporation Limited | Fusion proteins containing glutathione-s-transferase |
| EP0295859B1 (en) * | 1987-06-15 | 1994-11-17 | Southern Cross Biotech Pty.Ltd. | Production of proteins in active forms |
| AU609824B2 (en) * | 1987-06-15 | 1991-05-09 | Southern Cross Biotech Pty Ltd. | Production of proteins in active forms |
| US5266205A (en) * | 1988-02-04 | 1993-11-30 | Battelle Memorial Institute | Supercritical fluid reverse micelle separation |
| US5637566A (en) * | 1988-08-24 | 1997-06-10 | Southern Cross Biotech Pty. Ltd. | Method of improving carcass quality by administering growth hormone |
| US5136027A (en) * | 1989-05-02 | 1992-08-04 | Abbott Laboratories | Method for renaturing proteins in the presence of alkyl sulfate detergents |
| EP0444441B1 (en) * | 1990-03-01 | 1996-09-25 | Hewlett-Packard Company | Minimizing eluate band widths in liquid chromatography |
| US5530100A (en) * | 1990-05-07 | 1996-06-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Methods for purification of recombinantly produced proteins |
| EP0529201B1 (en) * | 1991-08-26 | 1997-09-24 | Hewlett-Packard Company | Chromatographic method with micellar on-column enrichment |
| US5252216A (en) * | 1992-03-24 | 1993-10-12 | Smithkline Beecham Corporation | Protein purification |
| CA2259927A1 (en) | 1996-07-12 | 1998-01-22 | Leukosite, Inc. | Chemokine receptor antagonists and methods of use therefor |
| ZA9711733B (en) | 1996-12-31 | 1998-07-01 | Monsanto Co | Method for solubilization and naturation of somatotropins |
| US20020052026A1 (en) | 1997-10-08 | 2002-05-02 | Steven M. Vicik | Methods of refolding proteins |
| DE69925917T2 (de) | 1998-08-06 | 2006-05-11 | Mountain View Pharmaceuticals, Inc., Menlo Park | PEG-Urikase Konjugate und Verwendung davon |
| JP2006507818A (ja) * | 2002-11-01 | 2006-03-09 | プロメガ コーポレイション | 細胞溶解のための組成物、使用方法、装置およびキット |
| DE10309691B4 (de) | 2003-02-28 | 2018-10-04 | Hans-Knöll-Institut für Naturstoff-Forschung e.V. | Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen |
| NZ562292A (en) | 2005-04-11 | 2009-11-27 | Savient Pharmaceuticals Inc | Variant forms of urate oxidase and use thereof |
| US20080159976A1 (en) * | 2005-04-11 | 2008-07-03 | Jacob Hartman | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
| US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
| TWI418564B (zh) * | 2005-04-11 | 2013-12-11 | Savient Pharmaceuticals Inc | 利用陽離子界面活性劑之蛋白質純化 |
| US7811800B2 (en) | 2005-04-11 | 2010-10-12 | Savient Pharmaceuticals, Inc. | Variant form of urate oxidase and use thereof |
| WO2006125452A1 (en) * | 2005-05-23 | 2006-11-30 | Universite De Geneve | Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
| NZ569004A (en) * | 2005-12-14 | 2011-08-26 | Denka Seiken Kk | Immunochromatographic detection method for multidrug-resistant staphylococcus and diagnostic kit |
| CN101622270B (zh) * | 2006-04-12 | 2014-01-01 | 萨文特医药公司 | 用阳离子表面活性剂纯化蛋白质的方法 |
| WO2008034016A2 (en) * | 2006-09-15 | 2008-03-20 | Foldrx Pharmaceuticals, Inc. | Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins |
| US9706787B2 (en) * | 2007-10-05 | 2017-07-18 | Advance International Inc. | Systems and methods for deriving protein powder |
| US8663725B2 (en) * | 2007-10-05 | 2014-03-04 | Advance International Inc. | Method for deriving a high-protein powder/ omega 3 oil and double distilled water from any kind of fish or animal ( protein) |
| BRPI1010069A2 (pt) | 2009-06-25 | 2016-03-15 | Savient Pharmaceuticals Inc | "método para prevenir reações à infusão durante terapia por uricase peguilada em pacientes; e método para diagnosticar se um paciente tratado com uricase peguilada desenvolverá reações à infusão ou desenvolverá liberação de uricase peguilada mediada por anticorpo sem a medição de títulos de anticorpos anti-peg e anti-uricase peguilada" |
| KR102067445B1 (ko) * | 2012-05-31 | 2020-01-17 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 양전하 유기 첨가물 처리에 의한 단백질-오염물 복합체 및 단백질 제제 내 응집체 레벨의 감소 방법 |
| US9826757B2 (en) | 2013-03-15 | 2017-11-28 | Advance International Inc. | Automated method and system for recovering protein powder meal, pure omega 3 oil and purified distilled water from animal tissue |
| WO2014192877A1 (ja) * | 2013-05-29 | 2014-12-04 | Jsr株式会社 | 洗浄用組成物、タンパク質精製方法、及びタンパク質 |
| JP2017506646A (ja) * | 2014-02-27 | 2017-03-09 | エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ | タンパク質調製物のクロマチン含有量をアルキルカチオン処理によって減少させる方法 |
| CA2920789C (en) | 2015-06-04 | 2021-05-18 | Advance International, Inc. | Improved methods and systems for recovering protein powder and natural omega-3 oil from animal tissue |
| JP2019535819A (ja) | 2016-11-11 | 2019-12-12 | ホライゾン ファーマ リューマトロジー リミテッド ライアビリティ カンパニーＨｏｒｉｚｏｎ Ｐｈａｒｍａ Ｒｈｅｕｍａｔｏｌｏｇｙ Ｌｌｃ | プレドニゾンおよびウリカーゼ分子の併用療法ならびにその使用 |
| US20200237881A1 (en) | 2019-01-30 | 2020-07-30 | Horizon Pharma Rheumatology Llc | Reducing immunogenicity to pegloticase |
| WO2019103106A1 (ja) * | 2017-11-22 | 2019-05-31 | 学校法人東京薬科大学 | 凝集タンパク質の再生剤およびこれを用いた凝集タンパク質の再生方法 |
| WO2020160322A1 (en) | 2019-01-30 | 2020-08-06 | Horizon Pharma Rheumatology Llc | Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple) |
| US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2829089A1 (de) * | 1977-07-13 | 1979-02-01 | Sandoz Ag | Subunit-vakzine |
| US4462940A (en) * | 1982-09-23 | 1984-07-31 | Cetus Corporation | Process for the recovery of human β-interferon-like polypeptides |
| US4659568A (en) * | 1985-02-27 | 1987-04-21 | American Cyanamid Company | Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom |
| US4656255A (en) * | 1985-09-09 | 1987-04-07 | International Minerals & Chemical Corp. | Protein recovery |
| ATE60595T1 (de) * | 1986-07-28 | 1991-02-15 | Allied Signal Inc | Sulfonierte benzotriazole und ihre verwendung in polyamiden. |
-
1985
- 1985-12-11 AU AU66874/86A patent/AU597924B2/en not_active Expired
-
1986
- 1986-12-09 US US06/939,578 patent/US4797474A/en not_active Expired - Lifetime
- 1986-12-10 EP EP86309603A patent/EP0226448B1/en not_active Expired - Lifetime
- 1986-12-10 ES ES198686309603T patent/ES2032194T3/es not_active Expired - Lifetime
- 1986-12-10 CA CA000524987A patent/CA1281849C/en not_active Expired - Lifetime
- 1986-12-10 NZ NZ218586A patent/NZ218586A/xx unknown
- 1986-12-10 NO NO864990A patent/NO864990L/no unknown
- 1986-12-10 DE DE8686309603T patent/DE3685562T2/de not_active Expired - Lifetime
- 1986-12-10 AT AT86309603T patent/ATE76878T1/de not_active IP Right Cessation
- 1986-12-10 DK DK592186A patent/DK171331B1/da not_active IP Right Cessation
- 1986-12-11 JP JP61295714A patent/JPH0660198B2/ja not_active Expired - Fee Related
- 1986-12-11 CN CN198686108729A patent/CN86108729A/zh active Pending
- 1986-12-11 MY MYPI86000197A patent/MY101204A/en unknown
-
1992
- 1992-06-11 GR GR920401248T patent/GR3004903T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ218586A (en) | 1989-07-27 |
| EP0226448A3 (en) | 1989-01-11 |
| NO864990D0 (no) | 1986-12-10 |
| NO864990L (no) | 1987-06-12 |
| DK592186A (da) | 1987-06-12 |
| DK171331B1 (da) | 1996-09-09 |
| GR3004903T3 (enExample) | 1993-04-28 |
| AU597924B2 (en) | 1990-06-14 |
| JPS62223192A (ja) | 1987-10-01 |
| ATE76878T1 (de) | 1992-06-15 |
| AU6687486A (en) | 1987-06-18 |
| CN86108729A (zh) | 1987-10-21 |
| JPH0660198B2 (ja) | 1994-08-10 |
| EP0226448B1 (en) | 1992-06-03 |
| EP0226448A2 (en) | 1987-06-24 |
| DE3685562D1 (de) | 1992-07-09 |
| US4797474A (en) | 1989-01-10 |
| DK592186D0 (da) | 1986-12-10 |
| CA1281849C (en) | 1991-03-19 |
| ES2032194T3 (es) | 1993-01-16 |
| DE3685562T2 (de) | 1992-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY101204A (en) | Solubilization of protein aggregates | |
| NZ225032A (en) | Method of extracting protein from microbial cells | |
| ATE345682T1 (de) | In vitro verfahren zum einbringen von nukleinsäuren in eine zelle | |
| DE3853430D1 (de) | Enzym-immunotestverfahren zum nachweis von hiv-antigenen in menschlichen seren. | |
| ZA839231B (en) | Molecular cloning and characterization of a further gene sequence coding for human relaxin | |
| ZA833668B (en) | Long dwell,short drift,magnetohydrostatic centrifuge and method | |
| FI882746A7 (fi) | Hybridiproteiini C ja menetelmä sen valmistamiseksi. | |
| DE3850592D1 (de) | Apparat zur Vorbereitung von Briefen. | |
| DE3764026D1 (de) | Verfahren zum aufbereiten von gebrauchten primaerzellen. | |
| DE3668022D1 (de) | Maschine zum herstellen von graeben im boden. | |
| DE3874820D1 (de) | Apparat zum herstellen von verschlossenen post- oder briefsendungen. | |
| DE3773121D1 (de) | Verfahren zum identifizieren gewebstypischer, unloeslicher cytoskelettproteine. | |
| FI853560A7 (fi) | Menetelmä pregnaani-johdannaisten valmistamiseksi. | |
| FI872310A7 (fi) | Menetelmä indiumin, germaniumin ja/tai galliumin talteenottamiseksi. | |
| GR3017286T3 (en) | Mineral fine-pulverising method, and pulveriser for carrying out this method. | |
| DE3763157D1 (de) | Vorrichtung zum beschleunigen von magnetisch beeinflussbarem strahlmittel. | |
| FI850970A7 (fi) | Menetelmä DL- -aryyliaminohappojen valmistamiseksi. | |
| EP0271964A3 (en) | Method for preparing protein hydrolysates soluble in an acid environment, and the hydrolysates obtained | |
| DE3774041D1 (de) | Apparat zum handhaben von boegen. | |
| BG37078A3 (en) | Method for preparing 6- methyl- 4. 6- 3- ketosteroides | |
| AU563449B2 (en) | Process for treating anestrus in ewes or beef cattle | |
| DE3871671D1 (de) | Verfahren zum herstellen von uran- und/oder plutoniumnitrid, verwendbar als kernbrennstoffmaterial. | |
| FI874565A7 (fi) | Metylotrofisissa mikro-organismeissa replikoituva hybridiplasmidi ja menetelmä sen valmistamiseksi. | |
| GR3003950T3 (enExample) | ||
| EP0172917A4 (en) | IMMUNODEFICIENCY TREATMENT AGENTS, THEIR TREATMENT PROCESS AND THEIR USE. |